Table 1.
ST | Allelic profile | Clonal complex | Antimicrobial susceptibility (no. of MRSA isolates/ no. of MSSA isolates) | Virulence profile |
Epidemiology (no. of HA isolates/no. of CA isolates) | |
---|---|---|---|---|---|---|
No. (%) of γ-hemolysin isolates | No. (%) of PVL isolates | |||||
5 | 1-4-1-4-12-1-10 | 5 | 0/1 | 1 (100) | 0 (0) | 1/0 |
6 | 12-4-1-4-12-1-3 | 6 | 0/6 | 4 (66) | 1 (17) | 5/1 |
8 | 3-3-1-1-4-4-3 | 8 | 0/18 | 14 (77) | 5 (28) | 15/3 |
15 | 13-13-1-1-12-11-13 | 15 | 1/0 | 1 (100) | 0 (0) | 1/0 |
22 | 7-6-1-5-8-8-6 | 22 | 0/7 | 6 (85) | 0 (0) | 6/1 |
25 | 4-1-4-1-5-5-4 | 25 | 1/1 | 1 (50) | 0 (0) | 2/0 |
30 | 2-2-2-2-6-3-2 | 30 | 0/5 | 3 (60) | 0 (0) | 2/3 |
46 | 10-14-8-6-14-3-2 | 45 | 0/1 | 1 (100) | 0 (0) | 1/0 |
88 | 22-1-14-23-12-4-31 | 88 | 0/3 | 3 (100) | 0 (0) | 2/1 |
97 | 3-1-1-1-1-5-3 | 97 | 0/2 | 2 (100) | 0 (0) | 2/0 |
239 | 2-3-1-1-4-4-3 | 8 | 7/0 | 6 (85) | 1 (14) | 6/1 |
291 | 3-37-19-2-20-26-32 | 398 | 3/1 | 4 (100) | 0 (0) | 3/1 |
378 | 2-2-2-1-6-3-2 | 30 | 1/0 | 1 (100) | 0 (0) | 0/1 |
585 | 2-1-1-1-4-4-3 | 8 | 0/1 | 1 (100) | 0 (0) | 1/0 |
672 | 4-3-1-1-11-72-11 | 672 | 0/3 | 3 (100) | 3 (100) | 3/0 |
859 | 79-1-14-23-12-4-31 | 88 | 4/1 | 4 (80) | 0 (0) | 5/0 |
938 | 2-2-2-6-6-3-2 | 30 | 0/3 | 2 (66) | 0 (0) | 2/1 |
1936a | 8-7-6-6-9-9-7 | 10 | 0/1 | 0 (0) | 0 (0) | 0/1 |
1937a | 3-37-19-6-20-26-32 | 398 | 0/2 | 2 (100) | 0 (0) | 1/1 |
1938a | 10-14-8-6-10-3-220 | 45 | 0/4 | 2 (50) | 1 (25) | 4/0 |
1939a | 4-3-1-1-11-4-11 | 672 | 0/2 | 2 (100) | 2 (100) | 1/1 |
1940a | 213-1-4-1-5-5-4 | 25 | 0/1 | 1 (100) | 0 (0) | 0/1 |
1941a | 7-1-1-1-1-1-1 | 15 | 0/1 | 1 (100) | 0 (0) | 1/0 |
1942a | 2-2-259-2-6-3-2 | 30 | 0/1 | 1 (100) | 0 (0) | 1/0 |
1947a | 1-6-1-5-8-8-64 | None | 0/1 | 1 (100) | 1 (100) | 1/0 |
Novel ST.